DOCS Doximity, Inc. Class A Common Stock
Über Doximity, Inc. Class A Common Stock Unternehmensübersicht von Wikipedia
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
Mehr lesen
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
The company is based in San Francisco.
History
The company was launched in March 2011 by co-founders Nate Gross, Jeff Tangney and Shari Buck.
In 2013, founder Jeff Tangney remained CEO while the company was based in San Mateo, California.
By 2013, it became one of the largest networks for U.S. healthcare professionals, with approximately 10 percent of U.S. doctors as members.
By the beginning of 2014, 40 percent of U.S. physicians became members. In 2016, it began offering a free service for doctors to call patients using their work number on their mobile phones. In 2018, the company announced that it had reached 1 million members, accounting for more than 70 percent of U.S. physicians. In 2021, Doximity served more than 2 million registered members, including over 80 percent of U.S. physicians and over 50 percent of nurse practitioners and physician assistants.
In 2016, the company was ranked #6 on the Deloitte Technology Fast 500 list.
In November 2019, Doximity was listed on the Deloitte Technology Fast 500 list for the fourth consecutive year.
In May 2020, the company added video. Dialer Video, a video telehealth app, allows physicians to video call patients through personal smartphones.
In June 2020, Doximity Acquires THMED and launches the Curative Brand. Curative is a staffing and recruiting company offering permanent and Locum/Temporary placement services.
In May 2021, Doximity, a professional network for physicians with telehealth and scheduling tools, filed for an initial public offering (IPO) seeking to raise $100 million. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities were the lead underwriters for the IPO. Doximity raised nearly $606 million in its IPO. In its June 2021 IPO on the NYSE, gave it a market cap shortly after its debut of $9.4 billion.
In 2021 August, CNBC reported that the site's news feed was "inundated" with vaccine misinformation shared among physicians, despite Doximity's community guidelines banning medical misinformation. AT the time, 80% of its revenue came from ads paid by pharmaceutical firms and hospitals, and directed at physicians on the site.
In November 2023, Doximity released DocDefender, a free service that removed a physician's personal phone numbers and addresses from public websites. Doximity continued to be used by around 80% of US doctors.
Investors
In April 2014, the company announced it had raised a $54 million financing round led by the venture capital firm Draper Fisher Jurvetson and the mutual fund company T. Rowe Price. Morgan Stanley Investment Management also invested. This investment brought Doximity's total funding to $81 million.
Doximity received $10.8 million in venture capital funding from Emergence Capital Partners and Interwest Partners in March 2011, and $17 million in Series B funding led by Morgenthaler Ventures in September 2012.
Products and services
Dialer
In 2016, Doximity built Dialer, a free communication tool for physicians to call their patients. The Doximity Dialer app allows physicians to call patients from their personal cell phone, and the patient sees the doctor's office number on caller ID.
Dialer Video
In May 2020, Doximity released Dialer Video, a telemedicine tool that allows physicians to video call their patients directly from their own smartphones.
In July 2020, Doximity said that more than 100,000 U.S. Doctors use Dialer Video, its telemedicine app.
Acquisition
In June 2020, Doximity acquired THMED, a healthcare company. Following the purchase, THMED changed its name to Curative and started concentrating on customized medical-personnel queries.
In February 2022, Doximity acquired Amion, an on-call doctor scheduling company.
In August 2025, Doximity acquired Pathway Medical, a Canadian startup specializing in medical AI and evidence-based clinical reference tools.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
DOCS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
DOCS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
DOCS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 5 17,9%
- Kauf 9 32,1%
- Halten 13 46,4%
- Verkauf 1 3,6%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
17 Analysten · 2026-08-15Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $0.29 | $0.31 | -0.02% |
| 31. März 2026 | $0.26 | $0.29 | -0.03% |
| 31. Dezember 2025 | $0.46 | $0.45 | 0.01% |
| 30. September 2025 | $0.45 | $0.39 | 0.06% |
| 30. Juni 2025 | $0.36 | $0.31 | 0.05% |
| 31. März 2025 | $0.46 | $0.45 | 0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| DOCS | $4.27B | 23.8 | 13.1% | 30.4% | 19.2% | 89.1% |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
| WAY | $6.27B | 53.7 | 16.5% | 10.2% | 3.2% | — |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | — | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| GDRX | — | 30.1 | 0.57% | 3.8% | 4.8% | — |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | — |
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | — |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | — |
| PHR | — | 335.8 | 14.5% | 0.48% | 0.73% | — |
| CTEV | $708M | -2.5 | 3.7% | -29.4% | 265.9% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $645M | $570M | $475M | $419M | $344M | $207M | $116M | |
| Cost of Revenue | $70M | $56M | $51M | $53M | $40M | $31M | $15M | |
| Gross Profit | $575M | $515M | $425M | $366M | $304M | $176M | $101M | |
| R&D Expense | $131M | $93M | $82M | $80M | $62M | $44M | $32M | |
| SG&A Expense | $65M | $46M | $38M | $37M | $36M | $16M | $7M | |
| Operating Expenses | $360M | $287M | $261M | $240M | $190M | $122M | $79M | |
| Operating Income | $215M | $228M | $164M | $125M | $114M | $53M | $22M | |
| Other Non-op | $-806.0K | $-247.0K | $62.0K | $-146.0K | $-448.0K | $4M | $1M | |
| Pretax Income | $250M | $264M | $185M | $133M | $114M | $58M | $24M | |
| Income Tax | $54M | $40M | $38M | $20M | $-41M | $8M | $-6M | |
| Net Income | $196M | $223M | $148M | $113M | $155M | $50M | $30M | |
| EPS (Basic) | $1.05 | $1.19 | $0.78 | $0.58 | $0.82 | $0.29 | $0.16 | |
| EPS (Diluted) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 | $0.13 | |
| Shares (Basic) | 187,014,000 | 186,841,000 | 190,172,000 | 193,176,000 | 163,484,000 | 74,342,000 | 66,758,000 | |
| Shares (Diluted) | 199,048,000 | 201,208,000 | 205,734,000 | 213,425,000 | 191,017,000 | 95,134,000 | 81,710,000 | |
| EBITDA | $229M | $238M | $174M | $135M | $119M | · | · |
Bilanz 24
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $219M | $210M | $97M | $158M | $113M | $66M | · | |
| Receivables | $145M | $128M | $101M | $107M | $81M | $50M | · | |
| Prepaid Expense | $51M | $45M | $49M | $27M | $19M | $11M | · | |
| Current Assets | $944M | $1.09B | $913M | $975M | $904M | $209M | · | |
| PP&E (Net) | $18M | $14M | $12M | $11M | $8M | $8M | · | |
| PP&E (Gross) | $49M | $39M | $31M | $25M | $17M | $12M | · | |
| Accum. Depreciation | $31M | $25M | $19M | $14M | $8M | $5M | · | |
| Goodwill | $85M | $68M | $68M | $68M | $19M | $19M | · | |
| Intangibles | $35M | $23M | $27M | $32M | $8M | $10M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $2M | $2M | $3M | · | |
| Total Assets | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Accounts Payable | $4M | $1M | $2M | $1M | $463.0K | $2M | · | |
| Accrued Liabilities | $43M | $38M | $44M | $31M | $25M | $16M | · | |
| Current Liabilities | $155M | $156M | $147M | $140M | $111M | $102M | · | |
| Capital Leases | $8M | $10M | $12M | $14M | $447.0K | $284.0K | · | |
| Other Non-current Liabilities | $9M | $9M | $7M | $1M | $956.0K | $972.0K | · | |
| Total Liabilities | $173M | $182M | $178M | $171M | $113M | $104M | · | |
| Common Stock | $183.0K | $189.0K | $187.0K | $194.0K | $192.0K | $83.0K | · | |
| Paid-in Capital | $1.00B | $894M | $824M | $762M | $703M | $30M | · | |
| Retained Earnings | $-51M | $187M | $80M | $218M | $191M | $36M | · | |
| AOCI | $28.0K | $1M | $-3M | $-14M | $-15M | $-21.0K | · | |
| Stockholders' Equity | $951M | $1.08B | $901M | $966M | $879M | $67M | $1M | |
| Liabilities + Equity | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Shares Outstanding | 183,060,000 | 188,875,000 | 186,562,000 | 193,941,000 | 192,398,000 | 82,910,000 | · |
Cashflow 15
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $11M | $10M | $10M | $5M | $4M | $900.0K | |
| Stock-based Comp | $122M | $72M | $51M | $48M | $31M | $7M | $2M | |
| Deferred Tax | $32M | $-12M | $-9M | $13M | $-41M | $5M | $-7M | |
| Amort. of Intangibles | $6M | $4M | $5M | $5M | $1M | $1M | $0 | |
| Restructuring | · | $2M | $8M | $0 | $0 | · | · | |
| Other Non-cash | $-38M | $-21M | $-16M | $-5M | $-23M | · | · | |
| Operating Cash Flow | $326M | $273M | $184M | $180M | $127M | $83M | $26M | |
| CapEx | $0 | $0 | $147.0K | $2M | $2M | $245.0K | $285.0K | |
| Investing Cash Flow | $147M | $-29M | $31M | $-60M | $-641M | $-70M | $-13M | |
| Stock Repurchased | $432M | $120M | $281M | $85M | $3M | $2M | $0 | |
| Net Stock Activity | $-432M | $-120M | $-281M | $-85M | $-3M | · | · | |
| Financing Cash Flow | $-464M | $-131M | $-277M | $-74M | $560M | $5M | $2M | |
| Net Change in Cash | $10M | $113M | $-61M | $45M | $46M | $18M | $15M | |
| Taxes Paid | $22M | · | · | · | · | · | · | |
| Free Cash Flow | $326M | $273M | $184M | $178M | $125M | · | · |
Rentabilität 8
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% | · | · | |
| Operating Margin | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% | · | · | |
| Net Margin | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | · | · | |
| Pretax Margin | 38.8% | 46.2% | 39.0% | 31.8% | 33.2% | · | · | |
| EBITDA Margin | 35.6% | 41.8% | 36.6% | 32.3% | 34.5% | · | · | |
| ROA | 16.4% | 19.1% | 13.3% | 10.6% | 24.9% | · | · | |
| ROE | 19.2% | 21.1% | 16.7% | 11.9% | 18.0% | · | · | |
| ROIC | 17.7% | 17.8% | 14.5% | 11.0% | 17.5% | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 | · | · | |
| Quick Ratio | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 | · | · |
Effizienz 2
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.4 | 0.4 | 0.6 | · | · | |
| Receivables Turnover | 4.7 | 5.0 | 4.6 | 4.5 | 5.2 | · | · |
Wachstumsraten 9
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.1% | 20.0% | 13.5% | 22.0% | 66.0% | · | · | |
| Revenue CAGR 3Y | 15.4% | 18.4% | 32.0% | · | · | · | · | |
| Revenue CAGR 5Y | 25.5% | · | · | · | · | · | · | |
| EPS YoY | -11.7% | 54.2% | 35.9% | -24.3% | 204.3% | · | · | |
| EPS CAGR 3Y | 22.7% | 16.6% | 46.3% | · | · | · | · | |
| EPS CAGR 5Y | 33.6% | · | · | · | · | · | · | |
| Net Income YoY | -12.2% | 51.2% | 30.8% | -27.1% | 208.3% | · | · | |
| Net Income CAGR 3Y | 20.2% | 13.0% | 43.2% | · | · | · | · | |
| Net Income CAGR 5Y | 31.3% | · | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $645M | $570M | $475M | $419M | $344M | · | · | |
| Net Income TTM | $196M | $223M | $148M | $113M | $155M | · | · | |
| Market Cap | $4.27B | $10.96B | $5.02B | $6.28B | $10.02B | · | · | |
| P/E | 23.8 | 52.3 | 37.4 | 61.1 | 74.4 | · | · | |
| P/S | 6.6 | 19.2 | 10.6 | 15.0 | 29.2 | · | · | |
| P/B | 4.5 | 10.1 | 5.6 | 6.5 | 11.4 | · | · | |
| P / Tangible Book | 5.1 | 11.1 | 6.2 | 7.2 | 11.8 | · | · | |
| P / Cash Flow | 13.1 | 40.1 | 27.3 | 35.0 | 79.2 | · | · | |
| P / FCF | 13.1 | 40.1 | 27.3 | 35.3 | 80.4 | · | · | |
| Earnings Yield | 4.2% | 1.9% | 2.7% | 1.6% | 1.3% | · | · |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $157M | $145M | $185M | $169M | $146M | $138M | $169M | $137M | $127M | $118M | $135M | $114M | $108M | $111M | $115M | $102M | |
| Cost of Revenue | $24M | $19M | $19M | $16M | $16M | $14M | $14M | $14M | $14M | $13M | $12M | $13M | $13M | $14M | $14M | $13M | |
| Gross Profit | $133M | $126M | $166M | $152M | $130M | $124M | $154M | $123M | $113M | $105M | $123M | $101M | $95M | $97M | $102M | $89M | |
| R&D Expense | $38M | $39M | $35M | $30M | $27M | $25M | $22M | $23M | $23M | $20M | $20M | $20M | $22M | $22M | $21M | $19M | |
| SG&A Expense | $16M | $16M | $18M | $19M | $12M | $13M | $14M | $10M | $9M | $10M | $10M | $9M | $9M | $10M | $10M | $9M | |
| Operating Expenses | $99M | $101M | $94M | $88M | $76M | $75M | $74M | $70M | $67M | $64M | $65M | $67M | $66M | $64M | $63M | $57M | |
| Operating Income | $34M | $25M | $72M | $64M | $55M | $49M | $80M | $53M | $46M | $42M | $59M | $34M | $30M | $33M | $38M | $32M | |
| Other Non-op | $-286.0K | $-235.0K | $-158.0K | $-178.0K | $-235.0K | $-51.0K | $-30.0K | $-114.0K | $-52.0K | $73.0K | $-55.0K | $-50.0K | $94.0K | $-27.0K | $-25.0K | $-48.0K | |
| Pretax Income | $40M | $32M | $81M | $73M | $64M | $58M | $90M | $62M | $53M | $48M | $63M | $40M | $35M | $37M | $41M | $33M | |
| Income Tax | $16M | $13M | $19M | $11M | $11M | $-4M | $15M | $18M | $12M | $7M | $15M | $9M | $6M | $6M | $7M | $7M | |
| Net Income | $24M | $19M | $62M | $62M | $53M | $62M | $75M | $44M | $41M | $41M | $48M | $31M | $28M | $31M | $33M | $26M | |
| EPS (Basic) | $0.13 | $0.11 | $0.33 | $0.33 | $0.28 | $0.33 | $0.40 | $0.24 | $0.22 | $0.21 | $0.26 | $0.16 | $0.15 | $0.15 | $0.17 | $0.14 | |
| EPS (Diluted) | $0.13 | $0.09 | $0.31 | $0.31 | $0.27 | $0.31 | $0.37 | $0.22 | $0.21 | $0.20 | $0.24 | $0.15 | $0.13 | $0.15 | $0.16 | $0.12 | |
| Shares (Basic) | 182,569,000 | -376,153,000 | 187,478,000 | 187,705,000 | 187,984,000 | -372,182,000 | 187,161,000 | 186,252,000 | 185,610,000 | -383,770,000 | 186,309,000 | 193,112,000 | 194,521,000 | -385,713,000 | 192,805,000 | 193,137,000 | |
| Shares (Diluted) | 191,169,000 | -402,079,000 | 199,224,000 | 200,745,000 | 201,158,000 | -400,656,000 | 202,233,000 | 200,407,000 | 199,224,000 | -416,098,000 | 200,463,000 | 209,014,000 | 212,355,000 | -427,543,000 | 212,065,000 | 213,949,000 | |
| EBITDA | $38M | · | $72M | $64M | $57M | · | $80M | $53M | $49M | · | $59M | $34M | $32M | · | $38M | $32M |
Bilanz 24
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $274M | $219M | $65M | $169M | $137M | $210M | $165M | $184M | $111M | $97M | $123M | $108M | $307M | · | $136M | $74M | |
| Receivables | $178M | $145M | $157M | $129M | $142M | $128M | $138M | $125M | $121M | $101M | $98M | $97M | $93M | · | $75M | $79M | |
| Prepaid Expense | $49M | $51M | $102M | $85M | $52M | $45M | $30M | $27M | $37M | $49M | $27M | $33M | $20M | · | $17M | $16M | |
| Current Assets | $914M | $944M | $993M | $1.09B | $1.03B | $1.09B | $1.01B | $958M | $908M | $913M | $841M | $863M | $990M | · | $899M | $848M | |
| PP&E (Net) | $19M | $18M | $17M | $16M | $14M | $14M | $13M | $13M | $13M | $12M | $12M | $12M | $12M | · | $12M | $12M | |
| PP&E (Gross) | $53M | $49M | $47M | $43M | $41M | $39M | $37M | $35M | $33M | $31M | $29M | $28M | $26M | · | $24M | $22M | |
| Accum. Depreciation | $34M | $31M | $30M | $28M | $26M | $25M | $23M | $22M | $21M | $19M | $18M | $16M | $15M | · | $12M | $11M | |
| Goodwill | $85M | $85M | $85M | $85M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | · | $68M | $68M | |
| Intangibles | $33M | $35M | $37M | $39M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | $29M | $31M | · | $33M | $34M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | · | $1M | $1M | |
| Total Assets | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Accounts Payable | $6M | $4M | $5M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $714.0K | $582.0K | · | $2M | $1M | |
| Accrued Liabilities | $33M | · | $77M | $34M | $38M | $38M | $43M | $34M | $28M | $44M | $34M | $29M | $32M | · | $33M | $26M | |
| Current Liabilities | $150M | $155M | $150M | $140M | $160M | $156M | $116M | $132M | $135M | $147M | $105M | $123M | $133M | · | $106M | $118M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | $13M | $14M | · | $14M | $15M | |
| Other Non-current Liabilities | $10M | $9M | $19M | $12M | $9M | $9M | $9M | $8M | $7M | $7M | $841.0K | $7M | $6M | · | $1M | $1M | |
| Total Liabilities | $168M | $173M | $178M | $162M | $179M | $182M | $141M | $157M | $160M | $178M | $136M | $154M | $163M | · | $137M | $149M | |
| Common Stock | $180.0K | $183.0K | $185.0K | $188.0K | $187.0K | $189.0K | $188.0K | $187.0K | $186.0K | $187.0K | $186.0K | $188.0K | $195.0K | · | $193.0K | $192.0K | |
| Paid-in Capital | $1.04B | $1.00B | $957M | $936M | $907M | $894M | $879M | $863M | $841M | $824M | $808M | $795M | $778M | · | $746M | $731M | |
| Retained Earnings | $-119M | $-51M | $21M | $158M | $117M | $187M | $151M | $95M | $73M | $80M | $61M | $85M | $225M | · | $203M | $170M | |
| AOCI | $-348.0K | $28.0K | $1M | $1M | $1M | $1M | $1M | $3M | $-1M | $-3M | $-5M | $-9M | $-12M | · | $-19M | $-22M | |
| Stockholders' Equity | $916M | $951M | $979M | $1.10B | $1.03B | $1.08B | $1.03B | $961M | $914M | $901M | $865M | $871M | $991M | $966M | $930M | $879M | |
| Liabilities + Equity | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Shares Outstanding | 179,849,000 | 183,060,000 | 184,992,000 | 188,090,000 | 187,453,000 | 188,875,000 | 187,584,000 | 186,781,000 | 185,704,000 | 186,562,000 | 186,175,000 | 188,518,000 | 194,649,000 | 193,941,000 | 193,252,000 | 192,302,000 |
Cashflow 15
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $37M | $37M | $34M | $29M | $22M | $18M | $19M | $18M | $17M | $12M | $12M | $13M | $14M | $13M | $14M | $11M | |
| Deferred Tax | · | $32M | $0 | · | · | $-14M | $2M | · | · | $-9M | $0 | $0 | $0 | $4M | $9M | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | $0 | $0 | $2M | · | $0 | $0 | $8M | · | $0 | $0 | $0 | |
| Other Non-cash | $-23M | · | · | · | $-16M | · | · | · | $-20M | · | · | · | $12M | · | · | · | |
| Operating Cash Flow | $42M | $110M | $61M | $94M | $62M | $98M | $65M | $68M | $41M | $64M | $50M | $13M | $57M | $47M | $49M | $40M | |
| CapEx | $62.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $36.0K | $41.0K | $70.0K | $21.0K | $204.0K | $766.0K | |
| Investing Cash Flow | $113M | $138M | $38M | $-32M | $3M | $-24M | $-59M | $24M | $30M | $-76M | $40M | $-50M | $117M | $-13M | $13M | $-19M | |
| Stock Repurchased | $92M | $91M | $197M | $22M | $122M | $27M | $19M | $23M | $51M | $18M | $77M | $164M | $22M | $15M | $0 | $61M | |
| Net Stock Activity | $-92M | · | · | · | $-122M | · | · | · | $-51M | · | · | · | $-22M | · | · | · | |
| Financing Cash Flow | $-101M | $-93M | $-204M | $-30M | $-137M | $-30M | $-25M | $-20M | $-57M | $-14M | $-76M | $-161M | $-26M | $-12M | $779.0K | $-57M | |
| Net Change in Cash | $54M | $154M | $-104M | $32M | $-72M | $44M | $-19M | $73M | $15M | $-26M | $15M | $-198M | $149M | $22M | $63M | $-36M | |
| Taxes Paid | · | · | · | · | · | · | $14M | $9M | $13M | · | $9M | $29M | $0 | · | $2M | · | |
| Free Cash Flow | $42M | · | · | · | · | · | · | · | $41M | · | · | · | $57M | · | · | · |
Rentabilität 8
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.9% | · | 89.9% | 90.2% | 89.2% | · | 91.6% | 90.0% | 89.3% | · | 91.0% | 88.8% | 87.9% | · | 88.3% | 87.1% | |
| Operating Margin | 21.5% | · | 38.9% | 37.8% | 37.4% | · | 47.4% | 38.8% | 36.4% | · | 43.3% | 29.7% | 27.4% | · | 33.4% | 31.4% | |
| Net Margin | 15.5% | · | 33.3% | 36.8% | 36.5% | · | 44.6% | 32.3% | 32.7% | · | 35.4% | 26.9% | 26.2% | · | 29.0% | 25.7% | |
| Pretax Margin | 25.8% | · | 43.7% | 43.3% | 44.0% | · | 53.3% | 45.4% | 42.0% | · | 46.6% | 34.9% | 31.8% | · | 35.5% | 32.3% | |
| EBITDA Margin | 24.2% | · | 38.9% | 37.8% | 39.3% | · | 47.4% | 38.8% | 38.4% | · | 43.3% | 29.7% | 29.8% | · | 33.4% | 31.4% | |
| ROA | 2.1% | · | 5.3% | 5.2% | 4.7% | · | 6.9% | 4.1% | 3.7% | · | 4.6% | 3.0% | 2.6% | · | 3.4% | 2.8% | |
| ROE | 2.5% | · | 6.1% | 6.0% | 5.5% | · | 7.9% | 4.8% | 4.3% | · | 5.3% | 3.5% | 3.0% | · | 3.8% | 3.2% | |
| ROIC | 2.2% | · | 5.6% | 5.0% | 4.4% | · | 6.5% | 3.9% | 3.9% | · | 5.1% | 3.0% | 2.5% | · | 3.4% | 2.9% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | · | 6.6 | 7.8 | 6.5 | · | 8.7 | 7.2 | 6.7 | · | 8.0 | 7.0 | 7.5 | · | 8.5 | 7.2 | |
| Quick Ratio | 3.0 | · | 1.5 | 2.1 | 1.7 | · | 2.6 | 2.3 | 1.7 | · | 2.1 | 1.7 | 3.0 | · | 2.0 | 1.3 |
Effizienz 2
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Receivables Turnover | 1.0 | · | 1.3 | 1.3 | 1.1 | · | 1.4 | 1.2 | 1.2 | · | 1.6 | 1.3 | 1.3 | · | 1.6 | 1.5 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $656M | · | $668M | $620M | $578M | · | $567M | $512M | $484M | · | $473M | $440M | $417M | · | $406M | $370M | |
| Net Income TTM | $201M | · | $252M | $235M | $214M | · | $209M | $164M | $148M | · | $140M | $119M | $111M | · | $138M | $140M | |
| Market Cap | $3.73B | · | $8.19B | $13.76B | $11.50B | · | $10.02B | $8.14B | $5.19B | · | $5.22B | $4.00B | $6.62B | · | $6.49B | $5.81B | |
| P/E | 20.3 | · | 35.1 | 62.5 | 57.3 | · | 51.3 | 53.1 | 38.3 | · | 41.2 | 37.9 | 66.7 | · | 52.4 | 46.5 | |
| P/S | 5.7 | · | 12.3 | 22.2 | 19.9 | · | 17.7 | 15.9 | 10.7 | · | 11.0 | 9.1 | 15.9 | · | 16.0 | 15.7 | |
| P/B | 4.1 | · | 8.4 | 12.6 | 11.2 | · | 9.7 | 8.5 | 5.7 | · | 6.0 | 4.6 | 6.7 | · | 7.0 | 6.6 | |
| P / Tangible Book | 4.7 | · | 9.6 | 14.2 | 12.3 | · | 10.7 | 9.4 | 6.3 | · | 6.8 | 5.2 | 7.4 | · | 7.8 | 7.5 | |
| P / Cash Flow | 88.8 | · | · | · | 185.2 | · | · | · | 125.9 | · | · | · | 115.8 | · | · | · | |
| P / FCF | 89.0 | · | · | · | · | · | · | · | 125.9 | · | · | · | 115.9 | · | · | · | |
| Earnings Yield | 4.9% | · | 2.9% | 1.6% | 1.7% | · | 1.9% | 1.9% | 2.6% | · | 2.4% | 2.6% | 1.5% | · | 1.9% | 2.1% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Umsatz | $645M | $570M | $475M | $419M | $344M |
| Bruttogewinnmarge % | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% |
| Betriebsgewinnmarge % | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% |
| Nettoergebnis | $196M | $223M | $148M | $113M | $155M |
| Verwässerte EPS | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 |
Bilanz
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 |
| Quick Ratio | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 |
Cashflow
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $326M | $273M | $184M | $178M | $125M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 414 Einreicher · $2.4B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 48 (-41 vs. Vorquartal) | 98 (-13 vs. Vorquartal) | 120 (-43 vs. Vorquartal) | 145 (+19 vs. Vorquartal) | +15.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $541.905.238 | 12.238.149 | 22,65% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $132.468.433 | 6.387.099 | 5,54% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $123.971.960 | 5.977.433 | 5,18% | Aktien |
| D. E. Shaw & Co., Inc. | $110.154.475 | 5.311.209 | 4,60% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $96.385.189 | 4.647.309 | 4,03% | Aktien |
| STATE STREET CORP | $87.334.253 | 4.210.909 | 3,65% | Aktien |
| GOLDMAN SACHS GROUP INC | $71.150.727 | 3.430.604 | 2,97% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $68.911.316 | 3.321.980 | 2,88% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $59.184.680 | 2.853.649 | 2,47% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $55.840.936 | 2.692.427 | 2,33% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $55.407.740 | 2.671.540 | 2,32% | Aktien |
| Carmignac Gestion | $48.861.366 | 2.355.900 | 2,04% | Aktien |
| Squarepoint Ops LLC | $45.090.336 | 2.174.076 | 1,88% | Aktien |
| LOOMIS SAYLES & CO L P | $44.354.523 | 2.138.598 | 1,85% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $42.902.785 | 2.068.601 | 1,79% | Aktien |
| NORGES BANK | $39.178.461 | 1.889.029 | 1,64% | Aktien |
| Gotham Asset Management, LLC | $35.523.762 | 1.712.814 | 1,48% | Aktien |
| Iron Triangle Partners LP | $30.401.231 | 686.568 | 1,27% | Aktien |
| Walleye Capital LLC | $29.032.972 | 1.399.854 | 1,21% | Aktien |
| Qube Research & Technologies Ltd | $26.585.445 | 1.281.844 | 1,11% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24.081.214 | 1.161.100 | 1,01% | Aktien |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $21.706.360 | 1.046.594 | 0,91% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $21.106.040 | 1.017.649 | 0,88% | Aktien |
| Swedbank AB | $20.958.994 | 1.010.559 | 0,88% | Aktien |
| BANK OF AMERICA CORP /DE/ | $19.149.532 | 923.314 | 0,80% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $17.517.170 | 844.608 | 0,73% | Aktien |
| ALGERT GLOBAL LLC | $16.161.002 | 779.219 | 0,68% | Aktien |
| BANK OF NOVA SCOTIA | $15.850.607 | 764.253 | 0,66% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $14.559.480 | 702.000 | 0,61% | Aktien |
| Fundsmith LLP | $13.549.940 | 653.324 | 0,57% | Aktien |
| JANE STREET GROUP, LLC | $12.967.830 | 625.257 | 0,54% | Aktien |
| Voleon Capital Management LP | $12.660.816 | 610.454 | 0,53% | Aktien |
| CAPITAL FUND MANAGEMENT S.A. | $12.189.354 | 587.722 | 0,51% | Aktien |
| ING GROEP NV | $11.890.242 | 573.300 | 0,50% | Aktien |
| Wilmington Savings Fund Society, FSB | $11.749.210 | 566.500 | 0,49% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $11.587.957 | 558.725 | 0,48% | Aktien |
| BlackRock, Inc. | $9.206.880 | 443.919 | 0,38% | Aktien |
| PEAK6 LLC | $9.123.526 | 439.900 | 0,38% | Verkaufsoption |
| Swiss Life Asset Management Ltd | $8.926.309 | 430.391 | 0,37% | Aktien |
| CITADEL ADVISORS LLC | $8.917.018 | 429.943 | 0,37% | Aktien |
| CITADEL ADVISORS LLC | $8.407.996 | 405.400 | 0,35% | Verkaufsoption |
| RICE HALL JAMES & ASSOCIATES, LLC | $8.187.737 | 394.780 | 0,34% | Aktien |
| Emergence GP Partners, LLC | $8.036.750 | 387.500 | 0,34% | Aktien |
| Trexquant Investment LP | $7.826.115 | 377.344 | 0,33% | Aktien |
| Clearbridge Investments, LLC | $7.727.143 | 372.572 | 0,32% | Aktien |
| Retirement Systems of Alabama | $7.339.202 | 353.867 | 0,31% | Aktien |
| WOLVERINE TRADING, LLC | $6.880.992 | 91.600 | 0,29% | Kaufoption |
| RHUMBLINE ADVISERS | $6.703.889 | 323.237 | 0,28% | Aktien |
| Liontrust Investment Partners LLP | $6.465.057 | 146.004 | 0,27% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.412.808 | 309.200 | 0,27% | Kaufoption |
| BARCLAYS PLC | $6.268.645 | 302.249 | 0,26% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.222.000 | 300.000 | 0,26% | Verkaufsoption |
| M&G PLC | $6.171.900 | 293.900 | 0,26% | Aktien |
| California Public Employees Retirement System | $6.126.679 | 295.404 | 0,26% | Aktien |
| Engineers Gate Manager LP | $5.915.007 | 285.198 | 0,25% | Aktien |
| RIVERBRIDGE PARTNERS LLC | $5.832.474 | 281.219 | 0,24% | Aktien |
| CITADEL ADVISORS LLC | $5.635.058 | 271.700 | 0,24% | Kaufoption |
| Edgestream Partners, L.P. | $5.545.917 | 267.402 | 0,23% | Aktien |
| JANE STREET GROUP, LLC | $5.330.180 | 257.000 | 0,22% | Verkaufsoption |
| Swiss National Bank | $5.012.858 | 241.700 | 0,21% | Aktien |
| OMERS ADMINISTRATION Corp | $4.942.176 | 238.292 | 0,21% | Aktien |
| Man Group plc | $4.865.874 | 234.613 | 0,20% | Aktien |
| EFG Asset Management (North America) Corp. | $4.717.796 | 64.486 | 0,20% | Aktien |
| NATIXIS | $4.528.351 | 218.339 | 0,19% | Aktien |
| WOLVERINE TRADING, LLC | $4.484.664 | 59.700 | 0,19% | Verkaufsoption |
| VOYA INVESTMENT MANAGEMENT LLC | $4.243.777 | 204.618 | 0,18% | Aktien |
| WHITTIER TRUST CO | $4.068.486 | 177.974 | 0,17% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $4.023.207 | 193.983 | 0,17% | Aktien |
| Brevan Howard Capital Management LP | $3.976.314 | 191.722 | 0,17% | Aktien |
| Quantbot Technologies LP | $3.776.630 | 182.094 | 0,16% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $3.708.195 | 159.150 | 0,15% | Aktien |
| AXQ CAPITAL, LP | $3.671.893 | 177.044 | 0,15% | Aktien |
| CAXTON ASSOCIATES LLP | $3.527.584 | 170.086 | 0,15% | Aktien |
| Mitsubishi UFJ Trust & Banking Corp | $3.509.291 | 169.204 | 0,15% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3.355.223 | 144.001 | 0,14% | Aktien |
| BAILLIE GIFFORD & CO | $3.350.879 | 161.566 | 0,14% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $3.266.114 | 157.479 | 0,14% | Aktien |
| Point72 Asset Management, L.P. | $3.169.072 | 152.800 | 0,13% | Verkaufsoption |
| Cresset Asset Management, LLC | $3.149.307 | 151.847 | 0,13% | Aktien |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $2.980.836 | 143.724 | 0,12% | Aktien |
| Bridgewater Associates, LP | $2.726.211 | 131.447 | 0,11% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $2.722.001 | 131.244 | 0,11% | Aktien |
| Sparta 24 Ltd. | $2.618.757 | 126.266 | 0,11% | Aktien |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2.574.129 | 58.133 | 0,11% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $2.422.266 | 116.792 | 0,10% | Aktien |
| Odyssean, LLC | $2.376.597 | 114.590 | 0,10% | Aktien |
| JANE STREET GROUP, LLC | $2.345.694 | 113.100 | 0,10% | Kaufoption |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2.257.777 | 108.861 | 0,09% | Aktien |
| Schonfeld Strategic Advisors LLC | $2.238.819 | 107.947 | 0,09% | Aktien |
| AMERIPRISE FINANCIAL INC | $2.224.759 | 107.269 | 0,09% | Aktien |
| EFG Asset Management (Americas) Corp. | $2.176.286 | 29.751 | 0,09% | Aktien |
| WHITTIER TRUST CO OF NEVADA INC | $2.136.946 | 93.973 | 0,09% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $2.117.224 | 90.868 | 0,09% | Aktien |
| CHILTON INVESTMENT CO INC. | $2.090.447 | 100.793 | 0,09% | Aktien |
| MACKENZIE FINANCIAL CORP | $2.070.080 | 99.811 | 0,09% | Aktien |
| Point72 Asset Management, L.P. | $2.020.076 | 97.400 | 0,08% | Kaufoption |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.015.596 | 97.184 | 0,08% | Aktien |
| Quantinno Capital Management LP | $1.925.356 | 92.833 | 0,08% | Aktien |
| XTX Topco Ltd | $1.875.249 | 90.417 | 0,08% | Aktien |
| Numerai GP LLC | $1.833.043 | 88.382 | 0,08% | Aktien |
Unternehmensinsider 8 Insider · 0 Führungskräfte · 2 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Regina M. Benjamin | Direktor | 13. Juli 2026 A | 50.903 | 0 | 0 | $0 |
| Kevin Spain | Direktor | 28. August 2025 A | 9.581 | 0 | 0 | $0 |
| Matthew Sonefeldt | — | 15. August 2026 F | 486.238 | 0 | 0 | $0 |
| Jeffrey Tangney | — | 15. August 2026 F | 2.531.955 | 0 | 0 | $0 |
| Steven L Zatz | — | 15. August 2026 F | 51.864 | 0 | 0 | $0 |
| Siddharth Sitaram | — | 13. August 2026 C | 93.122 | 0 | 3 | $-132.165 |
| Timothy S Cabral | — | 7. August 2026 C | 3.221 | 0 | 1 | $-293.325 |
| Gilbert H Kliman | — | 2. August 2022 D | 449.960 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 95 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| HEAL · Global X Funds | 2,56% | 29.929 NS | 31. Mai 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 1,86% | 344.667 SH | 8. August 2026 | Täglich |
| SMLL · Harbor ETF Trust | 1,54% | 8.705 NS | 30. April 2026 | N-PORT |
| MCOW · Pacer Funds Trust | 1,30% | 523 NS | 30. April 2026 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 0,60% | 1.237.748 SH | 8. August 2026 | Täglich |
| BUL · Pacer Funds Trust | 0,57% | 29.427 NS | 30. April 2026 | N-PORT |
| IHF · iShares Trust | 0,41% | 245.900 SH | 8. August 2026 | Täglich |
| COWG · Pacer Funds Trust | 0,39% | 349.637 NS | 30. April 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0,39% | 51.157 SH | 8. August 2026 | Täglich |
| CALF · Pacer Funds Trust | 0,35% | 493.056 NS | 30. April 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,31% | 23.780 NS | 31. Mai 2026 | N-PORT |
| ESUM · Strategy Shares | 0,23% | 14.226 NS | 30. April 2026 | N-PORT |
| FLOW · Global X Funds | 0,22% | 3.006 NS | 31. Mai 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,19% | 2.892 NS | 31. Mai 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,15% | 132.035 SH | 8. August 2026 | Täglich |
| IJK · iShares Trust | 0,15% | 783.542 SH | 8. August 2026 | Täglich |
| EWUS · iShares Trust | 0,13% | 50.934 SH | 8. August 2026 | Täglich |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 22.602 NS | 30. April 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,12% | 36.369 SH | 8. August 2026 | Täglich |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,12% | 18.788 SH | 8. August 2026 | Täglich |
| MIDE · DBX ETF Trust | 0,12% | 181 NS | 29. Mai 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,11% | 25.965 SH | 8. August 2026 | Täglich |
| FSMD · FIDELITY COVINGTON TRUST | 0,10% | 94.886 NS | 30. April 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,10% | 15.292 NS | 30. April 2026 | N-PORT |
| XJH · iShares Trust | 0,09% | 18.212 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,08% | 39.099 SH | 8. August 2026 | Täglich |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,08% | 215.901 SH | 8. August 2026 | Täglich |
| SMDX · Tidal Trust III | 0,08% | 3.911 NS | 30. April 2026 | N-PORT |
| IJH · iShares Trust | 0,08% | 4.616.253 SH | 8. August 2026 | Täglich |
| BKMC · BNY Mellon ETF Trust | 0,07% | 18.267 NS | 30. April 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,07% | 1.747.294 SH | 8. August 2026 | Täglich |
| MIDU · Direxion Shares ETF Trust | 0,06% | 2.216 NS | 30. April 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 52.692 NS | 30. April 2026 | N-PORT |
| MVV · ProShares Trust | 0,06% | 4.626 NS | 31. Mai 2026 | N-PORT |
| JSTC · Tidal Trust I | 0,06% | 9.533 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,06% | 640.841 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 56.967 SH | 8. August 2026 | Täglich |
| SCHM · SCHWAB STRATEGIC TRUST | 0,05% | 361.328 NS | 31. Mai 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 70.407 SH | 8. August 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,05% | 21.465 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,05% | 102.257 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 57.862 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,04% | 79.278 SH | 8. August 2026 | Täglich |
| UMDD · ProShares Trust | 0,04% | 646 NS | 31. Mai 2026 | N-PORT |
| IEUS · iShares Trust | 0,04% | 68.778 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,04% | 362.894 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,04% | 5.498 SH | 8. August 2026 | Täglich |
| SMMD · iShares Trust | 0,04% | 65.176 SH | 8. August 2026 | Täglich |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,03% | 16.664 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1.537.722 SH | 8. August 2026 | Täglich |